154 related articles for article (PubMed ID: 835136)
21. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.
Sagen JV; Pearson ER; Johansen A; Spyer G; Søvik O; Pedersen O; Njølstad PR; Hattersley AT; Hansen T
Diabet Med; 2005 Apr; 22(4):406-9. PubMed ID: 15787664
[TBL] [Abstract][Full Text] [Related]
22. Carbohydrate intolerance in gonadal dysgenesis: evidence for insulin resistance and hyperglucagonemia.
Costin G; Kogut MD
Horm Res; 1985; 22(4):260-9. PubMed ID: 3908274
[TBL] [Abstract][Full Text] [Related]
23. Further studies on healthy subjects with low and high insulin response to glucose infusion.
Cerasi E; Luft R
Acta Endocrinol (Copenh); 1967 Jun; 55(2):305-29. PubMed ID: 5338207
[No Abstract] [Full Text] [Related]
24. [Relations between the blood insulin and sugar response to oral glucos loading in normal subjects and in subclinical and manifest diabetes].
Coscelli C; Bobbioni E; Zavaroni I; Lugari R; Pezzarossa A
G Clin Med; 1974 Aug; 55(8):529-56. PubMed ID: 4464177
[No Abstract] [Full Text] [Related]
25. [Plasma insulin levels in endocrine diseases. I. Plasma insulin levels in normal subjects and diabetic patients].
Ikeda M
Nihon Naibunpi Gakkai Zasshi; 1971 Aug; 47(5):282-90. PubMed ID: 5106320
[No Abstract] [Full Text] [Related]
26. Modulation of A and B cell functions by tolbutamide and arginine in the pancreas of thiamine-deficient rats.
Rathanaswami P; Sundaresan R
Biochem Int; 1989 Oct; 19(4):793-802. PubMed ID: 2695088
[TBL] [Abstract][Full Text] [Related]
27. Amino acid modulation of glucose-induced insulin and glucagon release in diabetic patients.
Seino Y; Ikeda M; Nakane K; Nakahara H; Seino S
Metabolism; 1977 Aug; 26(8):911-9. PubMed ID: 875735
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of intravenous glucagon test in insulinoma.
Oneda A; Maruhama Y; Itabashi H; Horigome K; Yanbe A
Tohoku J Exp Med; 1975 Jul; 116(3):205-11. PubMed ID: 170711
[TBL] [Abstract][Full Text] [Related]
29. Plasma insulin disturbances in primary hyperparathyroidism.
Kim H; Kalkhoff RK; Costrini NV; Cerletty JM; Jacobson M
J Clin Invest; 1971 Dec; 50(12):2596-605. PubMed ID: 5129311
[TBL] [Abstract][Full Text] [Related]
30. [The importance of serum insulin determination in the diagnosis and treatment of diabetes mellitus (author's transl)].
Willms B
MMW Munch Med Wochenschr; 1975 Oct; 117(41):1643-8. PubMed ID: 810689
[TBL] [Abstract][Full Text] [Related]
31. Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics.
Serrano-Rios M; Ramos F; Rodriguez-Miñon JL; Vivanco F
Diabetologia; 1970 Aug; 6(4):392-8. PubMed ID: 5456764
[No Abstract] [Full Text] [Related]
32. Chemical diabetes mellitus in childhood. Report of a conference.
Rosenbloom AL; Drash A; Guthrie R
Diabetes; 1972 Jan; 21(1):45-9. PubMed ID: 5008085
[No Abstract] [Full Text] [Related]
33. Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians.
Aronoff SL; Bennett PH; Unger RH
J Clin Endocrinol Metab; 1977 May; 44(5):968-72. PubMed ID: 870519
[TBL] [Abstract][Full Text] [Related]
34. Glucagon and tolbutamide as insulin secretagogues in the pig (Sus domesticus).
Richardson RI; Weekes TE
Comp Biochem Physiol A Comp Physiol; 1982; 73(3):389-93. PubMed ID: 6128123
[TBL] [Abstract][Full Text] [Related]
35. Acute insulin response to glucagon, tolbutamide, and glucose in non-insulin-dependent diabetes of the young.
Naidoo C; Jialal I; Suleman A; Rajput MC; Joubert SM
Diabetes Care; 1986; 9(1):57-60. PubMed ID: 3512209
[TBL] [Abstract][Full Text] [Related]
36. Plasma immunoreactive insulin response to 100g-glucose-glucagon-tolbutamide stimulation in juvenile-onset diabetics.
Takeda R; Usukura N; Miwa U; Nakabayashi H; Kishitani M
Ala J Med Sci; 1977 Apr; 14(2):125-31. PubMed ID: 855893
[No Abstract] [Full Text] [Related]
37. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ; Prigeon RL; D'Alessio DA
Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
[TBL] [Abstract][Full Text] [Related]
38. Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation.
Færch K; Vistisen D; Pacini G; Torekov SS; Johansen NB; Witte DR; Jonsson A; Pedersen O; Hansen T; Lauritzen T; Jørgensen ME; Ahrén B; Holst JJ
Diabetes; 2016 Nov; 65(11):3473-3481. PubMed ID: 27504013
[TBL] [Abstract][Full Text] [Related]
39. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
Mokuda O; Murakami I; Ikeda T; Tominaga M; Mashiba H
Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183
[TBL] [Abstract][Full Text] [Related]
40. The effect of tolbutamide and hepatic extraction of insulin and glucagon and hepatic glucose output in anesthetized dogs.
Ishida T; Chou MC; Lewis RM; Hartley CJ; Entman M; Field JB
Endocrinology; 1981 Aug; 109(2):443-50. PubMed ID: 7018888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
